相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer
Xiang Li et al.
PANCREATOLOGY (2020)
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
Anouk E. J. Latenstein et al.
EUROPEAN JOURNAL OF CANCER (2020)
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older
Jonathan D. Mizrahi et al.
PANCREATOLOGY (2020)
Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies
Eran van Veldhuisen et al.
CANCERS (2019)
Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives
Marina Macchini et al.
CANCER TREATMENT REVIEWS (2019)
Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)
Mustafa Suker et al.
ECLINICALMEDICINE (2019)
Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX
Shawn L. Peterson et al.
ANTICANCER RESEARCH (2018)
Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis
Walid L. Shaib et al.
ONCOLOGIST (2018)
An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma
Elisabeth Castel-Kremer et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer
Ryan Nipp et al.
CANCER MEDICINE (2018)
Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study
Lydia G. M. van der Geest et al.
CANCER MEDICINE (2018)
Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble
Vasilis Kontis et al.
LANCET (2017)
Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis
C. Baldini et al.
PANCREATOLOGY (2017)
Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients
Taira Kuroda et al.
BMC GASTROENTEROLOGY (2017)
Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer
Takeshi Saito et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Deviations from Expected Treatment of Pancreatic Cancer in Octogenarians: Analysis of Patient and Surgeon Factors
Jonathan C. King et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
Steffi J. Rombouts et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Management of pancreatic cancer in the elderly
Oliver Higuera et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy
Jean-Florian Guion-Dusserre et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer
Makoto Kadokura et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices
Yu-Guang Chen et al.
MEDICINE (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
Hans Wildiers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Chemotherapy for advanced pancreatic adenocarcinoma in elderly patients (≥70 years of age): A retrospective cohort study at the National Center for Tumor Diseases Heidelberg
Anne Katrin Berger et al.
PANCREATOLOGY (2014)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Evidence for Treatment and Survival Disparities by Age in Pancreatic Adenocarcinoma A Population-Based Analysis
Sunil Amin et al.
PANCREAS (2013)
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
Faruk Tas et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
Yousuke Nakai et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Locally Advanced Pancreatic Cancer: Where Should We Go From Here?
Philip Agop Philip
JOURNAL OF CLINICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma
Yoshiyuki Yamagishi et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration
L Talarico et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Participation of patients 65 years of age or older in cancer clinical trials
JH Lewis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
